Atlas Trials

Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects

Clinical trial NCT02271113 · COMPLETED

Trial details

NCT number
NCT02271113
Sponsor
GlycoMimetics Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2014-10-01
Primary completion
2016-03-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.